Peregrine Capital Management’s Immunovant IMVT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-291,456	Closed	-$3.08M	–	339
2021 Q2	$3.08M	Sell	291,456 -15,547	-5%	-$164K	0.06%	256
2021 Q1	$4.92M	Buy	307,003 +142,386	+86%	+$2.28M	0.09%	255
2020 Q4	$7.6M	Sell	164,617 -15,048	-8%	-$695K	0.14%	244
2020 Q3	$6.32M	Buy	+179,665	New	+$6.32M	0.17%	193